Synthesis and antitumor activity of isolongifoleno[7,8‐
<i>d</i>
]thiazolo[3,2‐
<i>a</i>
]pyrimidine derivatives
<i>via</i>
enhancing ROS level
作者:Chonghui Ma、Yunyun Wang、Fuhao Dong、Zhonglong Wang、Yuxun Zhao、Yu Shan、Wen Gu、Shifa Wang
DOI:10.1111/cbdd.13522
日期:——
A series of novel isolongifoleno[7,8‐d]thiazolo[3,2‐a]pyrimidine derivatives (4a–4x) were synthesized from isolongifolanone according fragment‐based design strategy, and their anticancer activity against human aortic smooth muscle cells (HASMC), human breast cancer (MCF‐7) cells, human cervical cancer (HeLa) cells, and human liver cancer (HepG2) cells were investigated. Results of the anticancer activity
根据基于片段的设计策略,从异longifolanone合成了一系列新颖的异长ifoleno [7,8- d ]噻唑并[3,2- a ]嘧啶衍生物(4a – 4x),它们对人主动脉平滑肌细胞(HASMC)具有抗癌活性。 ),人类乳腺癌(MCF-7)细胞,人类宫颈癌(HeLa)细胞和人类肝癌(HepG2)细胞进行了研究。抗癌活性的结果表明,大多数化合物显示出有效的抗肿瘤活性,并且化合物4i被证明是IC 50活性最高的衍生物。值分别为0.33±0.24(对于MCF-7细胞),0.52±0.13(对于HeLa细胞)和3.09±0.11μM(对于HepG2细胞)。此外,我们评估了4i对细胞凋亡,细胞周期分布,线粒体膜电位和活性氧(ROS)生成的影响。结果表明,化合物4i改变了线粒体膜电位并产生ROS,导致MCF-7细胞的细胞凋亡呈剂量依赖性,但不影响细胞周期进程。这些发现表明4i是有效的化合物,并为抗癌药物提供了有希望的候选者。